SynthesisBMC global and public health2026
A qualitative evidence synthesis on perinatal screening for sickle cell disease in high-burden countries.
Synthesis in BMC global and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSickle cell disease (SCD) screening can improve lives and reduce mortality through prevention and targeted treatment, but screening programmes are not universally available in the settings which could most benefit from them. We aimed to understand the implementation considerations for prenatal and newborn SCD screening programmes in countries with a high livebirth prevalence of SCD using the socioecological model of health.
methodsWe performed a systematic review of qualitative evidence relating to prenatal and newborn screening programmes for SCD in the thirty countries with the highest SCD case to livebirth ratio. We included 18 papers published between 2004 and 2024 that covered nine countries and performed the Critical Appraisal Skills Programme Qualitative Studies Checklist on each. Through recursive interaction with our data, we interpretively developed four themes using reflexive thematic analysis and used the GRADE-CERqual method to appraise our key findings.
resultsWe framed our results using the socioecological model of health which organizes influences on health into individual, community, and systems levels. From macro to micro levels, our themes are (1) sustainable SCD screening programmes require financial and political support from government and integration into existing healthcare infrastructure, (2) experiences of and knowledge-sharing about SCD fosters further acceptance and opportunity for newborn screening, (3), the decision to conduct a SCD test has extensive ramifications for both child and family, and (4) prenatal and newborn screening modalities offer parents of affected children different options for action. Our policy suggestions focus on planning for programme sustainability at the outset, leveraging existing community knowledge, alleviating stigma, and providing different testing options for families.
conclusionsWe identified the need for more qualitative inquiry on systems-level implementation of SCD screening programmes and impact of external funding. We call for decreased stigmatization by supporting knowledge-sharing programmes grounded in local modes of understanding and recognize SCD screening decisions as both consequential to families and shaped by parents' experiences over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.